case | 14 Jun 2024
Setterwalls has advised Flerie in connection with directed share issue of approximately SEK 607 million
![Responsive image](https://setterwalls.se/wp-content/uploads/2021/12/Life-Science-microscope.jpg-1200x500.png)
Setterwalls has advised Flerie AB in connection with a directed share issue of approximately SEK 607 million to Swedish and international institutional investors.
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. The company’s ordinary shares are listed on Nasdaq First North Growth Market.
Contact:
Practice areas: